Dose Capping Enoxaparin Is Unjustified and Denies Patients With Acute Coronary Syndromes a Potentially Effective Treatment
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- June 2005
has subject area
- 1103 Clinical Sciences (FoR)
- Acute Disease (MeSH)
- Angina, Unstable (MeSH)
- Anticoagulants (MeSH)
- Biological Availability (MeSH)
- Clinical Trials as Topic (MeSH)
- Dose-Response Relationship, Drug (MeSH)
- Drug Administration Schedule (MeSH)
- Enoxaparin (MeSH)
- Female (MeSH)
- Follow-Up Studies (MeSH)
- Humans (MeSH)
- Male (MeSH)
- Maximum Tolerated Dose (MeSH)
- Myocardial Infarction (MeSH)
- Respiratory System (Science Metrix)
- Risk Assessment (MeSH)
- Severity of Illness Index (MeSH)
- Survival Analysis (MeSH)
- Treatment Outcome (MeSH)
published in
- Chest Journal